205 related articles for article (PubMed ID: 11923046)
1. The effect of supplemental L-arginine on tolerance development during continuous transdermal nitroglycerin therapy.
Parker JO; Parker JD; Caldwell RW; Farrell B; Kaesemeyer WH
J Am Coll Cardiol; 2002 Apr; 39(7):1199-203. PubMed ID: 11923046
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II-receptor antagonist losartan does not prevent nitroglycerin tolerance in patients with coronary artery disease.
Longobardi G; Ferrara N; Leosco D; Abete P; Furgi G; Cacciatore F; Corbi G; Pescatore R; Rengo F
Cardiovasc Drugs Ther; 2004 Sep; 18(5):363-70. PubMed ID: 15717138
[TBL] [Abstract][Full Text] [Related]
3. Intermittent transdermal nitroglycerin therapy. Decreased anginal threshold during the nitrate-free interval.
Parker JD; Parker AB; Farrell B; Parker JO
Circulation; 1995 Feb; 91(4):973-8. PubMed ID: 7850984
[TBL] [Abstract][Full Text] [Related]
4. Effects of intermittent transdermal nitroglycerin on occurrence of ischemia after patch removal: results of the second transdermal intermittent dosing evaluation study (TIDES-II).
Pepine CJ; Lopez LM; Bell DM; Handberg-Thurmond EM; Marks RG; McGorray S
J Am Coll Cardiol; 1997 Oct; 30(4):955-61. PubMed ID: 9316524
[TBL] [Abstract][Full Text] [Related]
5. Folic acid prevents nitroglycerin-induced nitric oxide synthase dysfunction and nitrate tolerance: a human in vivo study.
Gori T; Burstein JM; Ahmed S; Miner SE; Al-Hesayen A; Kelly S; Parker JD
Circulation; 2001 Sep; 104(10):1119-23. PubMed ID: 11535566
[TBL] [Abstract][Full Text] [Related]
6. Effects of diuretic therapy on the development of tolerance to nitroglycerin and exercise capacity in patients with chronic stable angina.
Parker JD; Parker AB; Farrell B; Parker JO
Circulation; 1996 Feb; 93(4):691-6. PubMed ID: 8640997
[TBL] [Abstract][Full Text] [Related]
7. Intermittent transdermal nitroglycerin therapy in angina pectoris. Clinically effective without tolerance or rebound. Minitran Efficacy Study Group.
Parker JO; Amies MH; Hawkinson RW; Heilman JM; Hougham AJ; Vollmer MC; Wilson RR
Circulation; 1995 Mar; 91(5):1368-74. PubMed ID: 7867175
[TBL] [Abstract][Full Text] [Related]
8. Intermittent transdermal nitrates do not improve ischemia in patients taking beta-blockers or calcium antagonists: potential role of rebound ischemia during the nitrate-free period.
Freedman SB; Daxini BV; Noyce D; Kelly DT
J Am Coll Cardiol; 1995 Feb; 25(2):349-55. PubMed ID: 7829787
[TBL] [Abstract][Full Text] [Related]
9. Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina.
DeMots H; Glasser SP
J Am Coll Cardiol; 1989 Mar; 13(4):786-95. PubMed ID: 2494240
[TBL] [Abstract][Full Text] [Related]
10. Comparison of buccal nitroglycerin and oral isosorbide dinitrate for nitrate tolerance in stable angina pectoris.
Parker JO; Vankoughnett KA; Farrell B
Am J Cardiol; 1985 Nov; 56(12):724-8. PubMed ID: 3933317
[TBL] [Abstract][Full Text] [Related]
11. Transdermal nitroglycerin: clinical and pharmacokinetic consequences of renewing the patch and the application site.
Klemsdal TO; Mundal HH; Bredesen JE; Gjesdal K
Eur J Clin Pharmacol; 1997; 52(5):379-81. PubMed ID: 9272407
[TBL] [Abstract][Full Text] [Related]
12. Acute and chronic antianginal efficacy of continuous twenty-four-hour application of transdermal nitroglycerin. Steering Committee, Transdermal Nitroglycerin Cooperative Study.
Am J Cardiol; 1991 Nov; 68(13):1263-73. PubMed ID: 1951111
[TBL] [Abstract][Full Text] [Related]
13. Antianginal efficacy of a new nitroglycerin patch.
Parker JO
Eur Heart J; 1989 May; 10 Suppl A():43-9. PubMed ID: 2501094
[TBL] [Abstract][Full Text] [Related]
14. The effect of hydralazine on the development of tolerance to continuous nitroglycerin.
Parker JD; Parker AB; Farrell B; Parker JO
J Pharmacol Exp Ther; 1997 Feb; 280(2):866-75. PubMed ID: 9023301
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of intermittent (eight hours off) transdermal nitrate therapy in stable angina.
Akhras F; Hellestrand K; Whalley D; Jackson G
Int J Cardiol; 1994 Mar; 43(3):251-6. PubMed ID: 8181883
[TBL] [Abstract][Full Text] [Related]
16. Efficacy, safety and duration of nitrate-free interval to prevent tolerance to transdermal nitroglycerin in effort angina.
Gumbrielle T; Freedman SB; Fogarty L; Ogasawara S; Sobb P; Kelly DT
Eur Heart J; 1992 May; 13(5):671-8. PubMed ID: 1618212
[TBL] [Abstract][Full Text] [Related]
17. Transdermal nitroglycerin in angina pectoris: efficacy of intermittent application.
Luke R; Sharpe N; Coxon R
J Am Coll Cardiol; 1987 Sep; 10(3):642-6. PubMed ID: 3114351
[TBL] [Abstract][Full Text] [Related]
18. [The development of tolerance to continuous transdermal nitroglycerin therapy in patients with angina of effort and mixed angina].
Cianfrocca C; Sabia R; Zoboli S; Bugiardini R
G Ital Cardiol; 1993 May; 23(5):439-49. PubMed ID: 8339869
[TBL] [Abstract][Full Text] [Related]
19. Antianginal effect of transdermal nitroglycerin and oral nitrates given for 24 hours a day in 2,456 patients with stable angina pectoris. The Italian Multicenter Study.
Savonitto S; Motolese M; Agabiti-Rosei E
Int J Clin Pharmacol Ther; 1995 Apr; 33(4):194-203. PubMed ID: 7620688
[TBL] [Abstract][Full Text] [Related]
20. Principles of transdermal nitroglycerin administration.
Wolff HM; Bonn R
Eur Heart J; 1989 May; 10 Suppl A():26-9. PubMed ID: 2501091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
